DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Bergh J, Jönsson PE, Lidbrink EK. et al.
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.

J Clin Oncol 2012;
30: 1919-1925

Download Bibliographical Data

Access:
Access:
Access: